FBXW4 and central nervous system cancer: Furthermore, diminished FBXW4 expression aligned with an increased risk of mortality.<h4>Conclusions</h4>The findings suggest that FBXW4 holds promise as a prognostic marker and a potential therapeutic avenue in glioma management.